Seqera

About:

Seqera makes complex data analysis accessible at any scale by providing the tools to drive innovation in genomics, global health, and beyond

Website: http://www.seqera.io

Twitter/X: seqeralabs

Top Investors: Creative Destruction Lab (CDL), Amino Collective, Talis Capital, Speedinvest, Chan Zuckerberg Initiative

Description:

Seqera makes complex data analysis accessible at any scale. Our software helps scientists solve today's most complex problems and drives innovation in genomics, global health, and beyond. Consolidating fragmented data and diverse computing resources into a unified platform, Seqera’s modern biotech stack is trusted by more than 150 leading life science organizations including AstraZeneca, Roche, and Johnson & Johnson. Scientists empowered with modern software engineering, conduct science faster, on larger datasets, and with more confidence. Seqera accelerates discoveries in an open world.

Total Funding Amount:

$27.5M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2018-07-01

Contact Email:

info(AT)seqera.io

Founders:

Evan Floden, Paolo Di Tommaso

Number of Employees:

51-100

Last Funding Date:

2022-10-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai